Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gordon

Showing results (1141-1150 of 1,291) with videos related to

Pageof 130
Sort By:
Journal of the American Academy of Dermatology|June 5, 2009
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agentsAlan Menter, Neil J Korman, Craig A Elmets, et al.
Journal of the American Academy of Dermatology|April 26, 2025
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trialAndrew Blauvelt, Richard G Langley, Mark Lebwohl, et al.
Iscience|January 5, 2026
High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human diseaseLudmila Szabova, Lucy Lu, Melanie B Gordon, et al.
Cardiology in the Young|November 21, 2024
The long-term vascular and myocardial outcomes in selected Kawasaki disease patients with regression of giant coronary artery aneurysmsSamuel C Kung, Koichi Miyata, Gabrielle M Colvert, et al.
European Journal of Pain (London, England)|August 19, 2014
PAIN OUT: the making of an international acute pain registryR Zaslansky, J Rothaug, C R Chapman, et al.
JAMA|August 25, 2011
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trialsCaitriona Ryan, Craig L Leonardi, James G Krueger, et al.
The Lancet. Global Health|November 10, 2021
Palliative care and catastrophic costs in Malawi after a diagnosis of advanced cancer: a prospective cohort studyMaya Jane Bates, Miriam R P Gordon, Stephen B Gordon, et al.
Nature Medicine|March 12, 2021
A targeted antisense therapeutic approach for Hutchinson-Gilford progeria syndromeMichael R Erdos, Wayne A Cabral, Urraca L Tavarez, et al.
Dermatology and Therapy|December 4, 2012
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1Bruce E Strober, Jennifer Clay Cather, David Cohen, et al.
The British Journal of Dermatology|December 31, 2019
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trialA Blauvelt, K Papp, A Gottlieb, et al.
Pageof 130

Showing results (1141-1150 of 1,291) with videos related to

Sort By:
Pageof 130
Journal of the American Academy of Dermatology|June 5, 2009
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agentsAlan Menter, Neil J Korman, Craig A Elmets, et al.
Journal of the American Academy of Dermatology|April 26, 2025
Bimekizumab durability of efficacy through 196 weeks and safety through 4 years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trialAndrew Blauvelt, Richard G Langley, Mark Lebwohl, et al.
Iscience|January 5, 2026
High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human diseaseLudmila Szabova, Lucy Lu, Melanie B Gordon, et al.
Cardiology in the Young|November 21, 2024
The long-term vascular and myocardial outcomes in selected Kawasaki disease patients with regression of giant coronary artery aneurysmsSamuel C Kung, Koichi Miyata, Gabrielle M Colvert, et al.
European Journal of Pain (London, England)|August 19, 2014
PAIN OUT: the making of an international acute pain registryR Zaslansky, J Rothaug, C R Chapman, et al.
JAMA|August 25, 2011
Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trialsCaitriona Ryan, Craig L Leonardi, James G Krueger, et al.
The Lancet. Global Health|November 10, 2021
Palliative care and catastrophic costs in Malawi after a diagnosis of advanced cancer: a prospective cohort studyMaya Jane Bates, Miriam R P Gordon, Stephen B Gordon, et al.
Nature Medicine|March 12, 2021
A targeted antisense therapeutic approach for Hutchinson-Gilford progeria syndromeMichael R Erdos, Wayne A Cabral, Urraca L Tavarez, et al.
Dermatology and Therapy|December 4, 2012
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1Bruce E Strober, Jennifer Clay Cather, David Cohen, et al.
The British Journal of Dermatology|December 31, 2019
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trialA Blauvelt, K Papp, A Gottlieb, et al.
Pageof 130